Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Generic Cholesterol Drugs Vital to Helping Consumers, Nation Lower Health-Care Costs
- To: MEDICAL EDITORSContact: Susan Herold or Steve Findlay of Consumers Union, +1-202- 462-6262 WASHINGTON, April 3 /PRNewswire-USNewswire/ -- As the maker of Lipitor reportedly urges doctors to carefully consider prescribing generics to lower cholesterol, Consumer Reports Best Buy Drugs reminds consumers that generic statins are as effective as high- priced...
- Research articles 2007-04-03
- Pfizer welcomes Canadian court's Lipitor ruling
- NEW YORK AFP — US drug giant Pfizer said it welcomed a ruling by Canada's Federal Court which prevents Novopharm Ltd. from launching a generic version of its blockbuster anti-cholesterol drug Lipitor until 2010. Pfizer had gone to court in a bid to stop Novopharm marketing a generic version of...
- Research articles 2006-12-08
- Pfizer Proves It Can Do More with Lipitor - Protecting Vital Access to Patients at the Heart of Winning Managed Care Strategy
- FEASTERVILLE, Pa. -- With Lipitor's formulary access constricting due to generic competition and looming patent expiration, Pfizer aims to extend the health of its flagship cholesterol reducer with an aggressive promotional regimen rivaling that of a new drug in its launch phase. During the first half of 2007 Lipitor was...
- Research articles 2007-08-30
- Lipitor faces first big generic hurdle
- As employers look to cut prescription drug costs, some consumers are finding Lipitor, the world's most popular drug, harder and more expensive to get. The leading anti-cholesterol drug is under pressure as employers push for use of lower-cost generics. In June, No. 2 anti-cholesterol drug Zocor went generic, setting...
- Research articles 2006-07-10
- Pfizer faces fresh lawsuits over Lipitor
- NEW YORK AFP — Two men filed personal injury suits against Pfizer, accusing the US pharmaceutical giant of concealing serious health risks associated with its blockbuster anti-cholesterol drug Lipitor. The suits, filed in New York Supreme Court, alleged that Pfizer promoted Lipitor as a safe drug, while failing to...
- Research articles 2006-06-08
- PFIZER INC - Statement re Lipitor.
- Pfizer Statement on Lipitor NEW YORK, June 9 -- In response to publicity generated by one plaintiff's attorney that may have created undue concerns for Lipitor patients and unnecessary confusion for health care professi ...
- Research articles 2006-06-09
- Business news in brief
- IN THE REGION Frankford Candy consolidates Phila. facilities Frankford Candy Co. said it had completed the consolidation of its three Philadelphia facilities into a $20 million, 500,000-square-foot building in the Northeast. The privately held company employs 200 and is among the top 10 suppliers of seasonal candy in...
- Research articles 2006-03-29
- New Analysis Finds Medicare, Taxpayers Could Save $8.2B a Year if Seniors Were Prescribed Generics for Cholesterol Reduction
- WASHINGTON, Jan. 11 /U.S. Newswire/ -- Potential savings of $8.2 billion could be achieved in 2007 if Medicare beneficiaries were prescribed effective, lower-cost generic statins to reduce cholesterol instead of higher-priced brands, according to a new analysis by Consumers Union and Consumer Reports Best Buy Drugs. The savings would...
- Research articles 2006-01-11
- PFIZER INC - Patent Decision.
- U.S. Patent Office To Issue Decision Confirming Validity of Pfizer's Crystalline Patent For Lipitor NEW YORK, Nov. 29...
- Research articles 2005-11-29
- PFIZER INC - Research Update.
- 'Only Lipitor Has Demonstrated Significant LDL Reductions and Cardiovascular Benefits for a Wide Range of Patients, With an Excellent Efficacy and Safety Profile Across the Full...
- Research articles 2006-03-13
- PFIZER INC - Regulatory Approval.
- FDA Approves Pfizer's LipitorR to Reduce Risk of Strokes and Heart Attacks in Patients With Diabetes Also Approved to Reduce...
- Research articles 2005-09-27
- Ranbaxy loses battle for Lipitor patent in Canada.
- Sep. 14--NEW DELHI -- In a setback for Ranbaxy in its global battle over the patent of Lipitor, a Canadian federal court has ruled that the company's generic drug Atorvastatin infringes upon one of Pfizer's Lipitor patent. However, the court dismisse Sep. 14--NEW DELHI -- In...
- Research articles 2007-09-14
- PFIZER INC - Research Update.
- Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease ...
- Research articles 2007-03-07
- Pfizer to Appeal German Court Decision in Lipitor Patent Case; Company Notes That Ruling Has No Immediate Commercial Impact
- NEW YORK -- Pfizer Inc said today that the Federal Patent Court in Munich, Germany has revoked the company's patent covering atorvastatin calcium, the active ingredient in Lipitor. The patent at issue in the lawsuit (EP 409,281) expires in July 2010.
- Research articles 2007-10-29
- United recalls 40 pilots
- United Airlines, the world's second-largest airline, is recalling 40 pilots for added international flights, including new service between the U.S. and China, Vietnam and Australia. United, operating under Chapter 11 bankruptcy court protection, needs pilots to replace those retiring or leaving the company as well, spokeswoman Jean Medina said in...
- Research articles 2004-09-03
- PFIZER INC - Research Update.
- Lipitor More Effective Than Simvastatin in Cutting Risk of Additional Heart Attacks in Patients Who Had a Recent Heart Attack, New Data Suggests * Heart Disease Patients who Were at a Very High Risk for Having a...
- Research articles 2006-09-06
- Study in Scotland Finds Cholesterol Drug May Fight Arthritis.
- By Delthia Ricks, Newsday, Melville, N.Y. Knight Ridder/Tribune Business News Jun. 19--Scientists in Scotland have found the first compelling evidence that statins -- the class of drugs capable of reducing cholesterol -- may also fight rheumatoid arthritis. A team...
- Research articles 2004-06-19
- Spanish Appellate Court Rules in Pfizer's Favor, Upholds Lipitor Patent
- NEW YORK -- Pfizer Inc said today that the Court of Appeal of Barcelona has upheld the company's enantiomer patent covering the calcium salt of atorvastatin, the active ingredient in Lipitor, reversing the lower court decision. The enantiomer patent expires in July 2010.
- Research articles 2008-03-31
- Pfizer hits patients' cell phones with Lipitor trials coupons
- PFIZER IS using text messaging to deliver Lipitor trial coupons to consumers.
- Research articles 2006-09-01
- PFIZER INC - Research Update.
- Lipitor's Safety Again Confirmed in Extensive Analysis of 49 Clinical Trials, Pfizer Says ...
- Research articles 2006-01-17
- << Previous
- page 1 of 3
- Next >>



